Willner & Heller’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,494
Closed -$265K 166
2025
Q2
$265K Sell
5,494
-615
-10% -$31.4K 0.22% 127
2025
Q1
$339K Buy
6,109
+800
+15% +$43.3K 0.31% 107
2024
Q4
$256K Hold
5,309
0.22% 131
2024
Q3
$306K Sell
5,309
-5
-0.1% -$270 0.27% 116
2024
Q2
$258K Sell
5,314
-220
-4% -$10.6K 0.25% 126
2024
Q1
$269K Buy
5,534
+100
+2% +$4.88K 0.27% 120
2023
Q4
$270K Buy
+5,434
New +$266K 0.3% 111
2022
Q4
$221K Sell
4,557
-798
-15% -$35K 0.31% 120
2022
Q3
$204K Buy
+5,355
New +$239K 0.33% 114
2022
Q2
Sell
-4,342
Closed -$218K 130
2022
Q1
$218K Sell
4,342
-549
-11% -$28.3K 0.27% 131
2021
Q4
$236K Buy
+4,891
New +$242K 0.31% 120

Other funds holding SNY

Willner & Heller's SNY Position: Q3 2025 in Review

Willner & Heller sold out of Sanofi (SNY) in Q3 2025, closing a stake of 5,494 shares — an estimated $265K sold.

Willner & Heller first reported a position in SNY in Q4 2021 and held it in 11 quarters. The position peaked at $339K in Q1 2025. 710 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Willner & Heller reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Willner & Heller sold 5,494 Sanofi shares in Q3 2025, an estimated $265K.
  • Willner & Heller first reported a position in Sanofi in Q4 2021 and held it in 11 quarters.
  • Willner & Heller's Sanofi position peaked at $339K in Q1 2025.
  • 710 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Willner & Heller's 13F filing for Q3 2025, filed 16 Oct 2025.